trial

Gender Differences in Social Cognition in Patients With Schizophrenia of Recent Diagnosis and Healthy Controls Subjects

NCTId NCT02575209
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 80 (actual)
Sponsored by Corporacion Parc Tauli
Primary completion 2016-07
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
80 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2015-09
Primary completion
2016-07
Eligibility
ALL · 18 Years · 45 Years

Interventions & indications

Drugs
GENDER

Sponsors

Corporacion Parc TauliLead Sponsor

Investigators

1
Sol Fernandez-Gonzalo, PhDPrincipal Investigator

Sites

1 total
Sabadell, Spain

Facts & assertions

4 sourced
Enrollment
80
Phase
NA
Primary Completion Date
2016-07
Status
COMPLETED
relationships
The graph out of here
drug
GENDER
drug
lead_sponsor
Corporacion Parc Tauli
company
indication
Men With Recent Diagnosis of Schizophrenia
indication
Healthy Men
indication
Women With Recent Diagnosis of Schizophrenia
indication
investigator
Sol Fernandez-Gonzalo, PhD
person